Northwire Canada EditionSaturday, July 11, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Cannabis

Page 15
  1. Apr 27, 2026 · 08:30 · LABS · Routine +

    US Rescheduling Confirmed, But Canadian Revenue Headwinds Loom

    MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling

    01
  2. Apr 27, 2026 · 08:00 · MDMA · Routine +

    PharmAla Biotech Monetizes APA-01 IP via SPV Amidst Psychedelic Regulatory Tailwinds

    PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01

    02
  3. Apr 27, 2026 · 07:31 · TRIP · Routine +

    M&A Approval Confirms Clinical Pivot, Dilution Looms

    Red Light Holland Announces Filament Health Shareholder Approval of Acquisition

    03
  4. Apr 27, 2026 · 03:02 · HERB · Routine +

    U.S. Rescheduling Tailwind Fails to Offset Persistent Losses and Related-Party Debt Risks

    Herbal Dispatch Advances U.S. Strategy amid Historic Cannabis Rescheduling Shift

    04
  5. Apr 24, 2026 · 08:30 · JUSH · Routine +

    Jushi Aligns Corporate Domicile with U.S. Operations Amidst Regulatory Shift

    Jushi Holdings Inc. Announces Proposed Continuance from British Columbia to Nevada

    05
  6. Apr 24, 2026 · 08:27 · TRIP · Routine +

    Red Light Holland Consolidates Psychedelic Supply Chain Amidst Dilutive Acquisition and Clinical Expansion

    Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments

    06
  7. Apr 24, 2026 · 03:02 · HERB · Routine +

    Herbal Dispatch Posts Q4 Profit, Yet Full-Year Loss Persists Amidst Cannabis Sector Volatility

    Herbal Dispatch Reports Q4 2025 Gross Sales of $6.2 Million, Achieves Positive Adjusted EBITDA, and Reports Full Year Gross Sales of $16.5 Million

    07
  8. Apr 23, 2026 · 17:01 · HYTN · Routine +

    HYTN Innovations Spins Off Peptide Unit as Cannabis Revenue Stabilizes

    HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business

    08
  9. Apr 23, 2026 · 13:24 · CL · Material +

    Federal Rescheduling Validates Business Model, But Debt Overhang Remains Key Risk

    Cresco Labs CEO: Rescheduling Ushers in a New Era of Care for Medical Cannabis Patients

    09
  10. Apr 23, 2026 · 09:55 · VRNO · Material +

    Verano Secures Regulatory Tailwind as Schedule III Confirmation Removes 280E Tax Overhang

    Verano Founder and Chief Executive Officer George Archos Celebrates Historic Announcement Confirming Cannabis Rescheduling to Schedule III

    10
  11. Apr 23, 2026 · 09:43 · JUSH · Material +

    Regulatory Shift Removes Tax Penalty, Debt Overhang Persists

    Jushi Holdings Inc. Applauds President Trump and Administration for Delivering on Cannabis Rescheduling to Schedule III under the Controlled Substances Act

    11
  12. Apr 23, 2026 · 08:53 · TLRY · Routine +

    Regulatory Tailwinds Meet Execution Reality as Tilray Consolidates Post-Rescheduling Gains

    Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling

    12
  13. Apr 23, 2026 · 08:45 · TRUL · Material +

    Trulieve Eyes Tax Relief as Cannabis Rescheduling Shifts Sector Economics

    Trulieve Applauds Trump Administration For Rescheduling Medical Marijuana to Schedule III

    13
  14. Apr 23, 2026 · 07:31 · PSYC · Routine +

    Policy Tailwinds Mask Lingering FDA Safety Overhangs in Psyched Wellness

    Psyched Wellness Highlights U.S. Federal Policy Momentum Supporting Psychedelic Sector

    14
← Newer Older →